Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cromolyn sodium vs mometasone vs azelastine nasal sprays for persistent allergic rhinitis
IRCT20260919071117N1Phase 3Recruiting
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Oct 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of sodium cromoglycate, mometasone and azelastine in allergic rhinitis (AR) (3 arms), sponsored by Zahedan University of Medical Sciences. Primary endpoints: Total Nasal Symptom Score change, Nasal congestion and 3 more. Started Oct 2026; status: recruiting.
02
Drugs
sodium cromoglycatemometasoneazelastine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on IRCT20260919071117N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260919071117N1.